国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000028 国药一致

已收盘 02-25 15:00:00

{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":25.85,"timestamp":1772002980000,"preClose":25.9,"halted":0,"volume":3748850,"delay":0,"changeRate":-0.0019,"floatShares":478000000,"shares":557000000,"eps":0.9596,"marketStatus":"已收盘","change":-0.05,"latestTime":"02-25 15:00:00","open":25.95,"high":26.17,"low":25.79,"amount":97436600,"amplitude":0.0147,"askPrice":25.86,"askSize":13,"bidPrice":25.85,"bidSize":32,"shortable":0,"etf":0,"ttmEps":0.9596,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":5,"adr":0,"adjPreClose":25.9,"symbolType":"stock","openAndCloseTimeList":[[1771983000000,1771990200000],[1771995600000,1772002800000]],"highLimit":28.49,"lowLimit":23.31,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"isCdr":false,"pbRate":0.78,"roa":"--","peRate":26.938308,"roe":"5.29%","epsLYR":1.15,"committee":0.443299,"marketValue":14387000000,"turnoverRate":0.0078,"status":1,"floatMarketCap":12358000000},"requestUrl":"/m/hq/s/000028/tweets","defaultTab":"tweets","newsList":[{"id":"2606269424","title":"国药控股(01099)：国药一致(000028.SZ)预计2025年归母净利约10.55亿元到12.15亿元 同比增长64.20%到89.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606269424","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606269424?lang=zh_cn&edition=full","pubTime":"2026-01-26 07:17","pubTimestamp":1769383064,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股(01099)发布公告，预计国药一致(000028.SZ)2025年度实现归属于上市公司股东的净利润10.55亿元到12.15亿元，同比增长64.20%到89.11%。预计2025年度实现归属于上市公司股东的扣除非经常性损益的净利润9.96亿元到11.56亿元，同比增加71.38%到98.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0175","01099","BK0188","BK1500","BK0185","LU0640798160.USD","LU1115378108.SGD","BK0196","BK1515","BK1197","BK0082","000028","BK0250","BK0010"],"gpt_icon":0},{"id":"2605870124","title":"股市必读：国药一致（000028）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605870124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605870124?lang=zh_cn&edition=full","pubTime":"2026-01-22 03:21","pubTimestamp":1769023304,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，国药一致报收于25.12元，下跌0.08%，换手率0.65%，成交量3.11万手，成交额7818.36万元。目前公司下属专业药房超150家，涉及慢性病用药、新特药等。国大药房通过强化商采体系，优化产品结构，战略性调整门店布局，有效提升了经营质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200002533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0028","000028","BK0010","BK0188","BK0196","BK0250","BK0175","BK0185"],"gpt_icon":0},{"id":"2605171192","title":"国药一致：国控广州获放射性药品经营许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171192?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:00","pubTimestamp":1768982425,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，关注要国药广州正式取得《放射性药品经营许可证》，根据广东省力争实现三级综合医院核医学科的全覆盖，请问贵公司当前是否正常开展了放射性药品的销售工作？国药一致回复：感谢您的关注！公司下属国控广州公司在取得相关许可证后，在放射性药品经营领域具备合法合规运营资质，将为公司拓展核医药健康业务筑牢根基，进一步赋能核医疗行业高质量发展。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100021982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0185","BK0250","BK0175","BK0082","BK0028","BK0010","000028"],"gpt_icon":0},{"id":"2605171862","title":"国药一致：每年对包含商誉的资产组进行减值测试","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171862?lang=zh_cn&edition=full","pubTime":"2026-01-21 15:54","pubTimestamp":1768982047,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致01月21日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100020886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0082","BK0250","000028","BK0196","BK0010","BK0175","BK0028","BK0188"],"gpt_icon":0},{"id":"2605797361","title":"国药一致：强化应收账款催收和考核力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2605797361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605797361?lang=zh_cn&edition=full","pubTime":"2026-01-21 15:51","pubTimestamp":1768981866,"startTime":"0","endTime":"0","summary":"公司高度重视应收账款风险管控，将从严资信管理、强化业务源头管控、加强应收账款催收和考核力度等方面不断完善应收账款监控机制，降低应收风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100020561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0250","000028","BK0185","BK0082","BK0028","BK0188","BK0010","BK0175"],"gpt_icon":0},{"id":"2603695359","title":"国药一致：积极引入先进生产力要素优化物流","url":"https://stock-news.laohu8.com/highlight/detail?id=2603695359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603695359?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:21","pubTimestamp":1768378870,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，国药一致（000028是否有机器人？部署83台多类型智能物流机器人，含四向穿梭车、CTU料箱机器人、潜伏式AGV、AI视觉机械臂等？福建国大塔埔店是否落地AI机器人药房，提供智能售药、用药指导？公司将根据业务发展需求，积极引入先进生产力要素，优化物流环节，实现降本增效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400024842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0028","BK0196","BK0250","BK0010","000028","BK0185","BK0082"],"gpt_icon":0},{"id":"2603953836","title":"国药一致：国大药房探索非药品类直播带货","url":"https://stock-news.laohu8.com/highlight/detail?id=2603953836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603953836?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378512,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，国药一致（000028）的国大药房是否在抖音、快手、小红书开设官方账号/店铺，主营OTC药品、医疗器械、保健食品、自有品牌等合规品类，在抖音、快手、小红书上销售？还在部分平台直播带货？国药一致回复：感谢您的关注！为更好的适配消费趋势、拓展经营边界，国大药房有尝试在部分网络渠道开展新媒体业务，目前主要是聚焦品牌形象展示，逐步探索非药品类直播带货。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400024156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0010","BK0185","BK0082","BK0196","BK0188","000028","BK0028","BK0250"],"gpt_icon":0},{"id":"2603969345","title":"国药一致：目前无代理脑机接口医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969345?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:09","pubTimestamp":1768378147,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：脑机接口是前沿学科，市场前景广阔，公司作为国内医药及医疗器械分销龙头之一，是否与脑机接口医疗器械相关公司达成了合作或代理意向？国药一致回复：感谢您的关注！公司作为医药分销企业会争取尽可能多的合作资源，目前无代理。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400023492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK1574","BK0185","BK0188","BK1222","09997","000028","BK1100","BK1583","BK0028","BK0082","BK0010","09996","BK0250","159883","BK0196"],"gpt_icon":0},{"id":"2602535586","title":"每周股票复盘：国药一致（000028）召开2025年第三次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2602535586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602535586?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:34","pubTimestamp":1768070050,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，国药一致报收于25.02元，较上周的24.56元上涨1.87%。本周，国药一致1月6日盘中最高价报25.07元。会议于2025年12月31日以现场与网络投票方式召开，审议通过《关于2025年度董事薪酬（津贴）的方案》。国药一致于2025年12月31日召开2025年第三次临时股东会，由董事会召集，采取现场与网络投票结合方式。北京市天元（深圳）律师事务所确认会议召集、召开程序及表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","000028","BK0196","BK0175","BK0010","BK0082","BK0250","BK0185"],"gpt_icon":0},{"id":"2601024506","title":"股市必读：国药一致（000028）12月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601024506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601024506?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:32","pubTimestamp":1767558730,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，国药一致报收于24.56元，下跌0.2%，换手率0.27%，成交量1.3万手，成交额3187.43万元。来自公司公告汇总：国药一致2025年第三次临时股东会审议通过《关于2025年度董事薪酬（津贴）的方案》，同意股份数占出席会议股份的99.06%。2025年第三次临时股东会决议公告国药集团一致药业股份有限公司于2025年12月31日召开2025年第三次临时股东会，会议由董事会召集，采用现场与网络投票相结合方式举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0196","BK0082","BK0010","000028","BK0028","BK0250","BK0175"],"gpt_icon":0},{"id":"2593410165","title":"股市必读：国药一致（000028）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593410165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593410165?lang=zh_cn&edition=full","pubTime":"2025-12-24 03:57","pubTimestamp":1766519830,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，国药一致报收于24.77元，下跌0.32%，换手率0.39%，成交量1.87万手，成交额4644.75万元。董秘最新回复投资者： 公司在海南有开展业务吗？下属子公司有参股嘉隆（海南）健康管理公司，主要开展依托实体医院的互联网医院服务等。当日关注点来自交易信息汇总：12月23日主力资金净流出383.48万元，散户资金净流入437.52万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400002685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","000028","BK0175","BK0082","BK0250","BK0185","BK0028","BK0010"],"gpt_icon":0},{"id":"2593600014","title":"国药一致：下属子公司参股海南互联网医院项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2593600014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593600014?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:21","pubTimestamp":1766478072,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致(000028)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在海南有开展业务吗？有哪些业务？国药一致回复：感谢您的关注！下属子公司有参股嘉隆（海南）健康管理公司，主要开展依托实体医院的互联网医院服务等。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300022569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0082","BK0010","BK0028","BK0250","BK0185","BK0175","BK0188","BK0196"],"gpt_icon":0},{"id":"2591642160","title":"国药一致（000028）披露召开2025年第三次临时股东会通知，12月15日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642160","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642160?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:31","pubTimestamp":1765809102,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，国药一致报收于24.61元，较前一交易日下跌0.32%，最新总市值为136.97亿元。该股当日开盘24.55元，最高24.68元，最低24.42元，成交额达5610.32万元，换手率为0.48%。公司近日发布公告称，国药集团一致药业股份有限公司将于2025年12月31日召开2025年第三次临时股东会，会议由董事会召集，现场会议地点为深圳市福田区八卦四路15号一致药业大厦5楼会议室。股权登记日为2025年12月24日，B股股东需在2025年12月19日或之前买入股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0185","BK0250","BK0175","BK0082","BK0028","BK0010","000028"],"gpt_icon":0},{"id":"2590502516","title":"国药一致（000028）披露拟清算注销三家子公司，12月12日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590502516?lang=zh_cn&edition=full","pubTime":"2025-12-12 22:27","pubTimestamp":1765549623,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘，国药一致报收于24.69元，较前一交易日下跌1.0%，最新总市值为137.42亿元。该股当日开盘24.94元，最高24.98元，最低24.52元，成交额达1.24亿元，换手率为1.05%。根据近日发布的第十届董事会2025年第八次临时会议决议公告，国药集团一致药业股份有限公司于2025年12月11日以通讯表决方式召开会议，审议通过多项议案。公告指出，上述清算注销事项不会对公司的整体业务经营产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200041868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000028","BK0196","BK0185","BK0082","BK0250","BK0175","BK0188","BK0010"],"gpt_icon":0},{"id":"2590230435","title":"国药一致：披露估值提升计划增进市场认同","url":"https://stock-news.laohu8.com/highlight/detail?id=2590230435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590230435?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:00","pubTimestamp":1765353623,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致12月10日在投资者关系平台上答复投资者关心的问题。请问公司管理层是否关注公司的投资价值，是否认可公司B股股价真实反映了公司质量？公司于11月29日披露了估值提升计划，将围绕稳经营、提质效，做强医药分销及零售主业，提高分红比率，加强与投资者交流，持续提升信息披露质量等方式增进市场认同，努力推动公司价值合理反映上市公司质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000020201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028","BK0082","BK0010","BK0028","BK0250","BK0185","BK0175","BK0188","BK0196"],"gpt_icon":0},{"id":"2586347733","title":"国药一致（000028）披露估值提升计划，11月28日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586347733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586347733?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:29","pubTimestamp":1764340193,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，国药一致报收于24.88元，较前一交易日下跌0.4%，最新总市值为138.47亿元。该股当日开盘25.02元，最高25.05元，最低24.83元，成交额达6124.9万元，换手率为0.51%。近日，国药集团一致药业股份有限公司发布公告称，因股票连续12个月每个交易日收盘价低于最近一个会计年度经审计的每股净资产，公司已触发估值提升计划制定条件。董事会认为该计划有助于提升公司投资价值和增强投资者回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0196","BK0188","BK0185","BK0175","BK0250","000028","BK0028","BK0082"],"gpt_icon":0},{"id":"2586243335","title":"国药一致：国大药房前三季度净利润同比大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586243335","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586243335?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:45","pubTimestamp":1764233111,"startTime":"0","endTime":"0","summary":"影响药房盈利的核心因素有很多，包括市场环境变化、品类聚焦效果、门店单店产出能力及成本控制水平等等，公司已通过战略性闭店、商品结构优化、统采体系升级等措施提升毛利率，国大药房前三季度净利润同比有较大幅度增长，展现提质增效成果。B股问题的解决需全面统筹考虑，不只取决于个别指标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700022827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2586248600","title":"国药一致：SPD业务处于成长期竞争激烈","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586248600?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232253,"startTime":"0","endTime":"0","summary":"证券之星消息，国药一致11月27日在投资者关系平台上答复投资者关心的问题。预计带来多少收益？SPD项目由医疗机构招投标确定，目前SPD业务在国内还处于成长期，在医疗机构的渗透处于提升阶段，竞争激烈，以收取服务费为主，公司作为医药分销企业仍为相关医疗机构提供配送服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700021298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0010","BK0185","BK0082","BK0196","BK0188","000028","BK0028","BK0250"],"gpt_icon":0},{"id":"2582806484","title":"股市必读：国药一致（000028）11月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582806484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582806484?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:22","pubTimestamp":1762795341,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，国药一致报收于25.79元，上涨0.98%，换手率0.87%，成交量4.14万手，成交额1.06亿元。董秘最新回复投资者： 董秘，你好！国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？后续将持续深化SPD业务布局。交易信息汇总资金流向11月10日主力资金净流出1261.22万元；游资资金净流出220.58万元；散户资金净流入1481.8万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100000559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0082","BK0185","BK0196","BK0010","BK0188","BK0175","BK0250","000028"],"gpt_icon":0},{"id":"2582982374","title":"国药一致：SPD业务持续深化发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2582982374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582982374?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:27","pubTimestamp":1762763230,"startTime":"0","endTime":"0","summary":"最近这五年，医院供应链延伸项目的医用耗材配送服务项目发展如火如荼，国药一致在广州深圳两地中标运营的项目有什么变化？国药一致器械业务的发展，还会不会继续去拿下更多的SPD业务？公司在SPD业务领域持续深化发展，通过强化中台服务能力和项目统筹管理，供应链增值服务项目数量在两广区域处于领先地位，有效构建标准化、高效率、可复制的服务能力。后续将持续深化SPD业务布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0196","BK0082","BK0010","000028","BK0028","BK0250","BK0175"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772028603686,"stockEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0133},{"period":"3month","weight":0.0327},{"period":"6month","weight":0.0109},{"period":"1year","weight":0.0129},{"period":"ytd","weight":0.0546}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0045},{"period":"3month","weight":0.0655},{"period":"6month","weight":0.0712},{"period":"1year","weight":0.2207},{"period":"ytd","weight":0.0374}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"0人","perCapita":"--","listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","registeredCapital":"55656万元","survey":"　　国药集团一致药业股份有限公司的主营业务是医药分销和医药零售。公司的主要产品是药品、器械耗材、诊断试剂、仪器设备。","listedPrice":3.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}